We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+7.4%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$362M
AUM Growth
+$130M
Cap. Flow
+$60.7M
Cap. Flow %
16.76%
Top 10 Hldgs %
69.22%
Holding
71
New
28
Increased
4
Reduced
7
Closed
16

Sector Composition

Rank Sector Weight
1 Healthcare 14.5%
2 Technology 3.17%
3 Industrials 2.43%
4 Consumer Discretionary 1.37%
5 Energy 1.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTI icon
1
Vanguard Morningstar Total Stock Market ETF
VTI
$646B
$156M 43.11%
765,000
+455,000
+147% +$91.1M
QQQ icon
2
Invesco QQQ Trust
QQQ
$436B
$18.3M 5.05%
57,000
+32,000
+128% +$9.44M
IWM icon
3
iShares Russell 2000 ETF
IWM
$79.1B
$16.9M 4.68%
+95,000
New +$17.5M
ALIT icon
4
Alight
ALIT
$534M
$8.75M 2.42%
47,500
-1,470
-3% -$270K
CMPX icon
5
Compass Therapeutics
CMPX
$349M
$7.12M 1.97%
2,177,042
-53,399
-2% -$210K
KRTX
6
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$5.18M 1.43%
+28,500
New +$5.45M
VKTX icon
7
Viking Therapeutics
VKTX
$3.88B
$5M 1.38%
+300,000
New +$3.1M
GTLS
8
DELISTED
Chart Industries
GTLS
$4.57M 1.26%
36,468
-63,532
-64% -$8.18M
RCL icon
9
Royal Caribbean
RCL
$86.5B
$4.24M 1.17%
+65,000
New +$4.29M
AER icon
10
AerCap
AER
$23.4B
$4.22M 1.16%
+75,000
New +$4.49M
GPCR icon
11
Structure Therapeutics
GPCR
$3.37B
$4.04M 1.12%
+170,000
New +$3.99M
ARGX icon
12
argenx
ARGX
$55.2B
$3.73M 1.03%
+10,000
New +$3.7M
ROIV icon
13
Roivant Sciences
ROIV
$23.6B
$3.69M 1.02%
500,000
+30,000
+6% +$247K
BHVN icon
14
Biohaven
BHVN
$2.02B
$3.42M 0.94%
250,000
+50,000
+25% +$796K
AESI icon
15
Atlas Energy Solutions
AESI
$1.27B
$3.41M 0.94%
+200,000
New +$3.28M
BMEA icon
16
Biomea Fusion
BMEA
$88.2M
$2.79M 0.77%
+90,000
New +$1.12M
SLGC
17
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$2.52M 0.7%
989,861
-10,139
-1% -$29K
AVDL
18
DELISTED
Avadel Pharmaceuticals
AVDL
$2.52M 0.7%
+275,000
New +$2.26M
BMBL icon
19
Bumble
BMBL
$387M
$2.44M 0.67%
+125,000
New +$2.82M
ANTX icon
20
AN2 Therapeutics
ANTX
$181M
$2.44M 0.67%
247,467
-202,533
-45% -$2.25M
LAUR icon
21
Laureate Education
LAUR
$5.38B
$2.44M 0.67%
207,323
-490,981
-70% -$5.4M
EOLS icon
22
Evolus
EOLS
$397M
$2.41M 0.67%
+285,000
New +$2.58M
ESMT
23
DELISTED
EngageSmart, Inc.
ESMT
$2.02M 0.56%
+105,000
New +$2.03M
MLYS icon
24
Mineralys Therapeutics
MLYS
$2.32B
$1.72M 0.48%
+110,000
New +$1.85M
TVTX icon
25
Travere Therapeutics
TVTX
$5.17B
$1.69M 0.47%
+75,000
New +$1.59M

Similar funds

Monashee Investment Management's Q1 2023 Portfolio in Review

As of Q1 2023, Monashee Investment Management held 71 positions worth $362M, up 56% from $232M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Monashee Investment Management deployed $60.7M of net new capital in Q1 2023, opening 28 new positions and adding to 4 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 95,000 shares worth $16.9M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Chart Industries, an estimated $8.18M trimmed.

  • Monashee Investment Management's largest Q1 2023 buy was iShares Russell 2000 ETF: 95,000 shares worth $16.9M.
  • Monashee Investment Management added most to Vanguard Morningstar Total Stock Market ETF in Q1 2023, an estimated $91.1M increase.
  • Monashee Investment Management's biggest Q1 2023 reduction was Chart Industries, cutting an estimated $8.18M.
  • Monashee Investment Management fully exited Constellation Brands in Q1 2023, selling an estimated $9.27M.
  • Monashee Investment Management's ten largest holdings make up 69% of its $362M portfolio in Q1 2023.
  • Monashee Investment Management opened 28 new positions and closed 16 in Q1 2023.
  • Monashee Investment Management's portfolio value rose 56% quarter-over-quarter to $362M.

Based on Monashee Investment Management's 13F filing for Q1 2023, filed 5 May 2023.